Udaipur

14 May 2018

KETAMINE: A MAGIC REMEDY

ABOUT AUTHORS
Kshitij Nuwal, Shailja Jain, Kamal S. Rathore
B.N.I.P.S., UDAIPUR
kshitij.nawal10@gmail.com

ABSTRACT:
The largest, longest study conducted on depression treatments, called the STAR*D trial, found that after people tried four antidepressants over the course of five years, about 70% of them were free of depressive symptoms. That’s a lot of trial and error to end at a place where 30% of patients don’t experience remission at all. The STAR*D trial ended in 2014, and despite a clear hole in the market–and a clear patient need–a golden age of new depression treatments still hasn’t arrived. The anesthetic ketamine could offer hope for people who don't have other depression treatment options. The most recent research on ketamine, as well as a statement from experts on its use published in April 2017, finds the drug works quickly, makes dramatic improvements in mood, and can work on people who haven’t gotten better with other depression treatments.

25 April 2018

Admission open in MBA Pharmaceutical Management at IIHMR University - Scholarships available

PROGRAM OVERVIEW
The University offers MBA Pharmaceutical Management. This educational program aims at developing trained professionals with requisite skills in planning and operating management techniques; diagnosing and solving management problems; and acquiring consultancy skills, with a view to preparing them to manage pharmaceutical industrial units. The in-take capacity of the program is 60.
As the program has set high standards of management education in the pharmaceutical management sector, it has attained the status of a premier program in the country. Our students go for training and placement to a large number of pharmaceutical organisations.